Huanling Zhu - West China Medical Center, Sichuan University

基本信息

浏览量：3

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 169 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Sudden Blast Crisis in a Chronic Myeloid Leukemia Patient in Treatment Free Remission: A Case Report and Literature Review

Qiushi Liang,Zhigang Liu, Yu Wu,Huanling Zhu, Yunfan Yang

Acta haematologicapp.1-8, (2024)

引用0浏览0WOS引用

Association Between Ferritin, Hemoglobin, and Anemia Response in Jaktinib-Treated Patients with Myelofibrosis: A Post-Hoc Analysis of the ZGJAK006 Study

Yi Zhang,Hu Zhou,Zhi-Jian Xiao,Minghui Duan,Sujun Gao,Guangsheng He,Hongmei Jing,Junmin Li,Liangming Ma,Huanling Zhu,Chunkang Chang,Xin Du,

Journal of Clinical Oncology（2024）

引用0浏览0引用

Oral Arsenic Plus Imatinib Versus Imatinib Solely for Newly Diagnosed Chronic Myeloid Leukemia: a Randomized Phase 3 Trial with 5-Year Outcomes

Jie Tian,Yong-Ping Song,Gao-Chong Zhang,Shu-Fang Wang, Xiao-Xiang Chu,Ye Chai,Chun-Ling Wang,Ai-Li He, Feng Zhang,Xu-Liang Shen,Wei-Hua Zhang,Lin-Hua Yang,

Journal of Cancer Research and Clinical Oncologyno. 4 (2024): 1-13

引用0浏览0WOS引用

Successful Maintenance of a Sustained Molecular Response in CML Patients Receiving Low-Dose Tyrosine Kinase Inhibitors

Yan Li,Pu Kuang,Huanling Zhu,Ling Pan,Tian Dong,Ting Lin, Yu Chen,Yunfan Yang

Therapeutic Advances in Hematology (2024)

引用0浏览0WOS引用

Safety and Efficacy of Flumatinib As Later-Line Therapy in Patients with Chronic Myeloid Leukemia

Yunfan Yang,Yuntao Liu,Hui Sun,Li Meng,Hai Lin,Chunyan Chen,Jianda Hu,Xuliang Shen,Minghui Duan,Yanli Zhang,Dilinazi Abulaiti,Jinghua Wang,

Haematologicano. 12 (2024): 3965-3974

引用0浏览0WOS引用

Treatment of Chronic-Phase Chronic Myeloid Leukemia in Patients Randomized to Dasatinib or Imatinib after Suboptimal Responses to 3 Months of Imatinib Therapy: Final 5-Year Results from DASCERN

Jorge E. Cortes,Qian Jiang,Jianxiang Wang,Jianyu Weng,Huanling Zhu,Xiaoli Liu,Andreas Hochhaus,Dong-Wook Kim,Jerald Radich,Michael Savona,Patricia Martin-Regueira,Oumar Sy,

HAEMATOLOGICAno. 10 (2024): 3251-3260

引用0浏览0WOS引用

Comparison of the Efficacy among Nilotinib, Dasatinib, Flumatinib and Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients: A Real-World Multi-Center Retrospective Study

Xiaoshuai Zhang,Na Xu,Yunfan Yang,Hai Lin,Bingcheng Liu,Xin Du,Xiaoli Liu,Rong Liang,Chunyan Chen,Jian Huang,Huanling Zhu,Ling Pan,

CLINICAL LYMPHOMA MYELOMA & LEUKEMIAno. 6 (2024): e257-e266

引用0浏览0WOS引用

Supplementary Fig. S3 from Flumatinib Versus Imatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: A Phase III, Randomized, Open-label, Multi-center FESTnd Study

Li Zhang,Li Meng,Bingcheng Liu,Yanli Zhang,Huanling Zhu,Jiuwei Cui, Aining Sun,Yu Hu,Jie Jin,Hao Jiang,Xi Zhang,Yan Li,

crossref（2023）

引用0浏览0引用

Quality‐of‐life, Mental Health, and Perspective on TKI Dose Reduction As a Prelude to Discontinuation in Chronic Phase Chronic Myeloid Leukemia

Yilin Chen,Na Xu,Yunfan Yang,Zhenfang Liu,Mengxing Xue,Li Meng,Qun He,Chunyan Chen,Qingshu Zeng,Huanling Zhu,Xin Du,Jing Zou,

CANCER MEDICINE (2023)

引用0浏览0WOS引用

Jaktinib in Patients (pts) with Myelofibrosis (MF) Who Were Intolerant to Ruxolitinib (RUX): an Open-Label, Single-Arm Phase 2b Study

Yi Zhang,Hu Zhou,Zhi-Jian Xiao,Minghui Duan,Sujun Gao,Guangsheng He,Hongmei Jing,Junmin Li,Liangming Ma,Huanling Zhu,Chunkang Chang,Xin Du,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn